Pacer Swan SOS Conservative (January) ETF (PSCX)
Live price chart, market sentiment, and community perspectives for Pacer Swan SOS Conservative (January) ETF (CBOE: PSCX).
Live price chart, market sentiment, and community perspectives for Pacer Swan SOS Conservative (January) ETF (CBOE: PSCX).
On our desk, we are monitoring PSCX's January series reset closely. With an upside cap of 11.97% and a buffer protecting against losses between -5% and -30%, it offers a predictable vehicle for risk-averse portfolios. However, the 0.49% expense ratio and limited liquidity given its $36M to $47M AUM range require patience on trade execution.
Watching the 50-day moving average around $32.60 and the 200-day moving average near $31.74, PSCX demonstrates steady technical footing. The sharp drop in short interest during July—falling over 54% to just 490 shares—indicates a complete lack of downward speculative pressure, aligning with its low beta of 0.37.
When evaluating structured outcome strategies for institutional clients, the mechanics of the Pacer Swan SOS Conservative fund deserve careful dissection. The underlying SPDR SandP 500 ETF Trust exposure is effectively structured to eliminate the first 5% of losses and buffer the tranche between -5% and -30%, though investors resume taking full downside risk past the 30% threshold.
As a risk manager assessing buffer ETFs, the key operational detail is the premium/discount stability to NAV. PSCX trades tightly around its net asset value—noted recently at a negligible -0.04% discount—which confirms that creation and redemption mechanisms are functioning smoothly despite modest average daily trading volumes.
From a market sentiment perspective, retail and aggregator channels on Twitter and StockTwits view PSCX as a textbook capital preservation tool. The 1-year target outcome period running from January 2, 2026, through December 31, 2026, anchors expectations clearly, preventing the panic-driven outflows seen in unhedged equity products during choppy sessions.
Explore plasma cleansing, somatic organ swaps, and BCI.